Monoaminergic synapses and schizophrenia: 45 Years of neuroleptics

Journal of Psychopharmacology

Volumn 12, Issue 3, 1998, Pages 289-304

  Bennett, Max R ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Chlorpromazine; Clozapine; Dopamine; Haloperidol; Monoamines; Neuroleptics; Schizophrenia; Serotonin

Indexed keywords

3 O METHYLDOPAMINE; ADENYLATE CYCLASE; BARBITURIC ACID DERIVATIVE; BRAIN RECEPTOR; CHLORDIAZEPOXIDE; CHLORPROMAZINE; CLOZAPINE; DOPAMINE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE RECEPTOR; DOPAMINE RECEPTOR BLOCKING AGENT; HALOPERIDOL; NEUROLEPTIC AGENT; NORADRENALIN; NORMETADRENALIN; RESERPINE; SEROTONIN;

DRUG MECHANISM; DRUG RECEPTOR BINDING; HUMAN; MENTAL PATIENT; MOLECULAR CLONING; MONOAMINE NERVE CELL; NEUROTRANSMISSION; PRIORITY JOURNAL; RECEPTOR DENSITY; REVIEW; SCHIZOPHRENIA; SYNAPSE; SYNAPTIC TRANSMISSION;

EID: 0031736497     PISSN: 02698811     EISSN: None     Source Type: Journal    
DOI: 10.1177/026988119801200310     Document Type: Review

References (124)

1. Amin A H, Crawford T B B, Gaddum J H (1954) The distribution of substance P and 5-hydroxytryptamine in the central nervous system of the dog. J Physiol 126: 596-618
2. Anden N E, Roos B E, Werdinius B (1964) Effects of chlorpromazine, haloperidol and reserpine on the levels of phenolic acids in rabbit corpus striatum. Life Sci 3: 149-158
3. Anden N E, Dahlstrom A, Fuxe K, Larsson K (1966) Functional role of the nigro-neostriatal dopamine neurons. Acta Pharmac Toxicol 24: 263-274
4. Anden N E, Butcher S G, Fuxe K (1970) Protection of the neostriatal dopamine stores against reserpine by local treatment with metatyramine. Acta Pharmac Toxicol 28: 39-48
5. 2 receptors. Nature 377: 424-428
6. Bennett M R (1997) The idea of consciousness. Harwood Academic Press, London
7. Bertler A, Carlsson A, Rosengren E (1956) Release by reserpine of catechol amines from rabbits' hearts. Naturwissenschaften 22: 521
8. 125I]iodosulpride. Neuroscience 20: 117-155
9. Bruderlein F T, Humber L G (1975) Neuroleptic agents of the benzocycloheptapyridoisoquinoline series. 1 Syntheses and stereochemical and structural requirements for activity of butaclamol and related compounds. J Med Chem 18: 185-188
10. 2 dopamine receptor cDNA. Nature 336: 783-787
11. Burt D R, Enna S J, Creese I, Snyder S H (1975) Dopamine receptor binding in the corpus striatum of mammalian brain. Proc Nat Acad Sci USA 72: 4655-4659
12. Busatto G F, Kerwin R W (1997) Perspectives on the role of serotonergic mechanisms in the pharmacology of schizophrenia. J Psychopharmac 11: 3-12
13. Carlos J, Niemegeers E, Janssen P A J (1979) A systematic study of the pharmacological activities of dopamine antagonists. Life Sci 24: 2201-2216
14. Carlsson A (1978) Mechanism of action of neuroleptic drugs. In Lipton M A, DiMascio A, Killman K F (eds), Psychopharmacology. A generation of progress. Raven Press, New York, pp. 1057-1070
15. Carlsson A (1996) The rise of neuropsychopharmacology: impact on basic and clinical science. In Healy D (ed.) The psychopharmacologists. Chapman & Hall, New York, pp. 51-80
16. Carlsson A, Hillarp N A (1956) Kgl Fysiogr Sallsk Lund Forhandl 26: No 8
17. Carlsson A, Waldeck B (1958) A fluorimetric method for the determination of dopamine (3-hydroxytyramine). Acta Physiol Scand 44: 293
18. Carlsson A, Lindqvist M (1963) Effect of chlorpromazine or haloperidol on formation of 3-methoxytyramine and normetanephrine in mouse brain. Acta Pharmac Toxicol 20: 140-144
19. Carlsson M, Carlsson A (1990) Interactions between glutamatergic and monoaminergic systems within the basal ganglia - implications for schizophrenia and Parkinsons disease. Trends Neurosci 13: 272-276
20. Carlsson A, Rosengren E, Bertler A, Nilsson J (1957) In Garattini S, Ghetti V (eds), Psychotropic drugs. Elsevier, Amsterdam, pp. 363-372
21. Castellano M A, Liu LX, Monsma F J Jr, Sibley D R, Kapatos G, Chiodo L A (1993) Transfected D2 short dopamine receptors inhibit voltage-dependent potassium current in neuroblastoma × glioma hybrid (NG108-15) cells. Molec Pharmac 44: 649-656
22. Charpentier P (1947) Sur la constitution d'un dimethylamino-N-phenothiazine. CR Hebd Séanc Acad Sci 225: 306-308
23. Charuchinda C, Supavilai P, Karobath M, Palacios JM (1987) Dopamine D2 receptors in the rat brain: autoradiographic visualization using a high-affinity selective agonist ligand. J Neurosci 7: 1352-1360
24. Clement-Cormier Y C, Kebabian J W, Petzold G L, Greengard P (1974) Dopamine-sensitive adenylate cyclase in mammalian brain: a possible site of action of antipsychotic drugs. Proc Nat Acad Sci USA 71: 1113-1117
25. Creese I, Burt D R, Snyder S H (1976) Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs. Science 192: 481-483
26. Dal Toso R, Sommer B, Ewert M, Herb A, Pritchett D B, Bach A, Shivers B D, Seeburg P H (1989) The dopamine D2 receptor: two molecular forms generated by alternative splicing. EMBO J 8: 4025-4034
27. Delay J, Deniker P (1952) Le traitment des psychoses par une méthode neurolytique derivée de l'hibernothérapie. CR 50e Congres des aliénistes et neurol de langue Fse 495-502
28. Delay J, Deniker P (1957) In Garattini S, Ghetti V (eds) Psychotropic drugs. Elsevier, Amsterdam, pp. 485-501
29. Delay J, Deniker P, Harl J M (1952) Utilisation en thérapeutique psychiatrique d'une phenothiazine d'action centrale éléctive. Ann Méd Psychol 110: 112-117
30. Delay J, Deniker P, Tardieu Y, Lemperiere Th (1954) Premiers essais en thérapeutique psychiatrique de la réserpine, alcalooide nouveau de la Rauwolfia serpentina. CR 52c Congres des aliénistes et neurol de langue Fse 836-841
31. Deniker P (1970) Introduction of neuroleptic chemotherapy into psychiatry. In Ayd F J, Blackwell B (eds), Discoveries in biological psychiatry. Lippincott, Philadelphia, pp. 155-163
32. Deniker P (1989) From chlorpromazine to tardive dyskinesia (brief history of the neuroleptics). Psychiat J Univ Ottawa 14: 253-259
33. Deniker P (1990) The neuroleptics: a historical survey. Acta Psychiat Scand 82 (Suppl. 358): 83-87
34. Di Marzo V, Vial D, Sokoloff P, Schwartz J C, Piomelli D (1993) Selection of alternative G-mediated signaling pathways at the dopamine D2 receptor by protein kinase C. J Neurosci 13: 4846-4853
35. Divry P, Bobon J, Collard J, Pinchard A, Nols E (1959) Étude et expérimentation cliniques du R 1625 ou haloperidol, nouveau neuroleptique et 'neurodystleptique'. Acta Neurol Psychol (Belg) 59: 337-367
36. Farde L (1996) The advantage of using positron emission tomography in drug research. Trends Neurosci 19: 211-214
37. 11C]raclopride. Archs Gen Psychiat 47: 213-219
38. Gaddum J H (1954) In Ciba Foundation symposium on hypertension: humoral and neurogenic factors. Little Brown, Boston, MA, pp. 75-77
39. Garattini S (1996) The role of independent science in psychopharmacology. In Healy D (ed.), The psychopharmacologists. Chapman & Hall, New York, pp. 153-158
40. Gaspar P, Bloch B, Le Moine C (1995) D1 and D2 receptor gene expression in the rat frontal cortex: cellular localization in different classes of efferent neurons. Eur J Neurosci 7: 1050-1063
41. Gingrich J A, Caron M G (1993) Recent advances in the molecular biology of dopamine receptors. Ann Rev Neurosci 16: 299-321
42. 2 dopamine receptor isoforms. Nature 324: 923-926
43. Goldsmith S K, Joyce J N (1994) Dopamine D2 receptor expression in hippocampus and parahippocampal cortex of rat, cat and human in relation to tyrosine hydroxylase-immunoreactive fibers. Hippocampus 4: 354-373
44. Grace A A, Bunney B S, Moore H, Todd C L (1997) Dopamine-cell depolarization block as a model for the therapeutic actions of antipsychotic drugs. Trends Neurosci 20: 31-37
45. Grandy D K, Litt M, Allen L, Bunzow J R, Marchionni M, Makam H, Reed L, Magenis R E, Civelli O (1989) The human dopamine D2 receptor gene is located on chromosome 11 at q22-q23 and identifies a TaqI RFLP. Am J Hum Gen 45: 778-785
46. Grandy D K, Zhang Y A, Bouvier C, Zhou Q Y, Johnson R A, Allen L, Buck K, Bunzow J R, Salon J, Civelli O (1991) Multiple human D5 dopamine receptor genes: a functional receptor and two pseudogenes. Proc Nat Acad Sci USA 88: 9175-9179
47. Graybiel A M, Moratalla R, Robertson H A (1990) Amphetamine and cocaine induce drug-specific activation of the c-fos gene in striosoma-matrix compartments and limbic subdivisions of the striatum. Proc Nat Acad Sci USA 87: 6912-6916
48. Gross H, Langner E, Pfolz H (1974) Clozapin in long-term therapy of chronic schizophrenia. Arzneim-Forsch 24: 987-989
49. 125I] epidepride. Synapse 23: 115-123
50. Hamon M (1989) Dopamine and serotonin. Involvement in the central effects of psychotropic agents. Encéphale 15 Spec. No: 119-125
51. Hell J W, Yokoyama C T, Wong S T, Warner C, Shutch T P, Catterall W A (1993) Differential phosphorylation of two size forms of the neuronal class C L-type calcium channel alpha 1 subunit. J Biol Chem 268: 19451-19457
52. Hemmings H C Jr, Nairn A C, Elliott J I, Greengard P (1990) Synthetic peptide analogs of DARPP-32 (Mr 32,000 dopamine-and cAMP-regulated phosphoprotein), an inhibitor of protein phosphatase - 1. Phosphorylation, dephosphorylation and inhibitory activity. J Biol Chem 265: 20369-20376
53. Hippius H (1989) The history of clozapine. Psychopharmacology 99: S3-S5
54. Hippius H (1996) The founding of the CINP and the discovery of clozapine. In Healy D (ed.), The psychopharmacologists. Chapman & Hall, New York, pp. 187-214
55. Hunziker F, Kunzle F, Schmutz J (1963) Helv Chim Acta 42: 2337
56. Janssen P (1970) The butyrophenone story. In Ayd F J, Blackwell B (eds), Discoveries in biological psychiatry. Lippincott, Philadelphia, pp. 165-179
57. Joyce J N (1993) The dopamine hypothesis of schizophrenia: limbic interactions with serotonin and norepinephrine. Psychopharmacology 112(Suppl. 1): S16-S34
58. Joyce J N, Lexow N, Bird E, Winokur A (1988) Organization of dopamine D1 and D2 receptors in human striatum: receptor autoradiographic studies in Huntington's disease and schizophrenia. Synapse 2: 546-557
59. Kebabian J W, Greengard P (1971) Dopamine-sensitive adenyl cyclase: possible role in synaptic transmission. Science 174: 1346-1349
60. Kebabian J W, Calne D B (1979) Multiple receptors for dopamine. Nature 277: 93-96
61. Kebabian J W, Petzold G L, Greengard P (1972) Dopamine-sensitive adenylate cyclase in caudate nucleus of rat brain, and its similarity to the 'dopamine receptor'. Proc Nat Acad Sci USA 69: 2145-2149
62. 2 receptor stimulation differentially affects voltage-activated calcium channels in rat pituitary melanotropic cells. J Physiol 450: 409-435
63. Laborit H, Huguenard P, Alluaume R (1952) Un nouveau stabilisateur végétatif (LE4560 RP). Presse Méd 60: 206-208
64. 2 receptors. Psychopharmacology 112 (Suppl 1): S40-S54
65. Libet B, Tosaka T (1970) Dopamine as a synaptic transmitter and modulator in sympathetic ganglia: a different mode of synaptic action. Proc Nat Acad Sci USA 67: 667-673
66. Liu L X, Kapatos G, Chiodo L A (1992) DA autoreceptor modulation of different calcium currents. Soc Neurosci Abstr 18: 1516
67. Lledo P M, Legendre P, Israel J M, Vincent J D (1990) Dopamine inhibits two characterized voltage-dependent calcium currents in identified rat lactotroph cells. Endocrinology 127: 990-1001
68. Meador-Woodruff J H, Grandy D K, Van Tol H H, Damask S P, Little K Y, Civelk O, Watson S J (1994) Dopamine receptor gene expression in the human medial temporal lobe. Neuropsychopharmacology 10: 239-248
69. Meltzer H Y, Nash J F (1991) Effects of antipsychotic drugs on serotonin receptors. Pharmac Rev 43: 587-604
70. Müller J M, Schlitter E, Bein H J (1952) Reserpen, der sedative Wirkstoff aus Rauwolfia serpentina Benth. Experientia 8: 388-391
71. Murray A M, Hyde T M, Knable M B, Herman M M, Bigelow L B, Carter J M, Weinberger D R, Kleinman J E (1995) Distribution of putative D4 dopamine receptors in postmortem striatum from patients with schizophrenia. J Neurosci 15: 2186-2191
72. Nanko S, Hattori M, Ikeda K, Sasaki T, Kazamatsuri H, Kuwata S (1993) Dopamine D4 receptor polymorphism and schizophrenia. Lancet 341: 689-690
73. Neve K A, Henningsen R A, Bunzow J R, Civelli O (1989) Functional characterization of rat dopamine D-2 receptor cDNA expressed in a mammalian cell line. Molec Pharmac 36: 446-451
74. Nguyen T V, Kosofsky B E, Birnbaum R, Cohen B M, Hyman S E (1992) Differential expression of c-fos and zif268 in rat striatum after haloperidol, clozapine, and amphetamine. Proc Nat Acad Sci USA 89: 4270-4274
75. Niemegeers C J E, Janssen P A J (1979) A systematic study of the pharmacological activities of dopamine antagonists. Life Sci 24: 2201-2216
76. Niznik N B (1987) Dopamine receptors: molecular structure and function. Molec Cell Endocrinol 54: 1-22
77. 1-receptors. Biochemistry 28: 6925-6930
78. 14C in mouse brain. Effect of some phenothiazine analogues. Eur J Pharmac 10: 193-205
79. O'Malley K L, Harmon S, Tang L, Todd R D (1992) The rat dopamine D4 receptor: sequence, gene structure, and demonstration of expression in the cardiovascular system. New Biologist 4: 137-146
80. Piochet P (1996) The discovery of chlorpromazine and the place of psychopharmacology in the history of psychiatry. In Healy D (ed.), The psychopharmacologists. Chapman & Hall, New York, pp. 1-28
81. Reynolds G P (1997) 5-HT receptors, genes and antipsychotic mechanisms. J Psychopharmac 11: 26-27
82. Reynolds G P, Mason S L (1994) Are striatal dopamine D4 receptors increased in schizophrenia? J Neurochem 63: 1576-1577
83. Rossum J M van (1966) The significance of dopamine-receptor blockade for the mechanism of action of neuroleptic drugs. Archs Int Pharmacodyn Ther 160: 492-494
84. Roufogalis B D, Thornton M, Wade D N (1976) Specificity of the dopamine sensitive adenylate cyclase for antipsychotic antagonists. Life Sci 19: 927-934
85. Schmutz J, Eichenberger E (1982) Clozapine. In Lednicer D (ed.), Chronicles of drug discovery, Vol. 1. John Wiley, New York, pp. 39-59
86. Seeman P (1980) Dopamine receptors. Pharmac Rev 32: 229-313
87. Seeman P (1981) Dopamine receptors in post-mortem schizophrenic brains. Lancet i: 1103
88. 4. Neuropsychopharmacology 7: 261-284
89. Seeman P, Niznik H B (1990) Dopamine receptors and transporters in Parkinsons disease and schizophrenia. FASEB J 4: 2737-2744
90. Seeman P, Van Tol HHM (1994) Dopamine receptor pharmacology. Trends Pharmac Sci 15: 264-270
91. 3H] nemonapride. J Neurochem 64: 1413-1415
92. 4 receptor varies with the affinity of the competing radioligand. Eur J Pharmac 291: 59-66
93. Seeman P, Chau-Wong M, Tedesco J, Wong K (1975) Brain receptors for antipsychotic drugs and dopamine: direct binding assays. Proc Nat Acad Sci USA 72: 4376-4380
94. 3H]apomorphine and an antipsychotic drug. Proc Nat Acad Sci USA 73: 4354-4358
95. Seeman P, Bzowej N H, Guan H C, Bergeron C, Reynolds G P, Bird E D, Riederer P, Jellinger K, Tourtellotte W W (1987) Human brain D1 and D2 dopamine receptors in schizophrenia, Alzheimer's Parkinson's, and Huntington's diseases. Neuropsychopharmacology 1: 5-15
96. Seeman P, Niznik H B, Guan H C, Booth G, Ulpian C (1989) Link between D1 and D2 dopamine receptors is reduced in schizophrenia and Huntington diseased brain. Proc Nat Acad Sci USA 86: 10156-10160
97. 4 receptors elevated in schizophrenia. Nature 365: 441-445
98. 2A subtype. DNA 8: 683-689
99. Sen S, Bose K C (1931) Rauwolfia serpentina, a new Indian drug for insanity and high blood pressure. Ind Med Wd 2: 194-198
100. Sibley D R, Monsma F J Jr (1992) Molecular biology of dopamine receptor. Trends Pharmac Sci 13: 61-69
101. 4 receptor subtypes and response to clozapine. Lancet 341: 116
102. Skarsfeldt T (1988) Differential effects after repeated treatment with haloperidol, clozapine, thioridazine and tefludazine on SNC and VTA dopamine neurones in rats. Life Sci 42: 1037-1044
103. Snyder G L, Girault J A, Chen J Y, Czernik A J, Kebabian J W, Nathanson J A, Greengard P (1992) Phosphorylation of DARPP-32 and protein phosphatase inhibitor-1 in rat choroid plexus: regulation by factors other than dopamine. J Neurosci 12: 3071-3080
104. 3) as a target for neuroleptics. Nature 347: 146-151
105. Spano P F, Govoni S, Travucci M (1978) Studies on the pharmacological properties of dopamine receptors in various areas of the central nervous system. Adv Biochem Psychopharmac 19: 155-165
106. Stack J, Surprenant A (1991) Dopamine actions on calcium currents, potassium currents and hormone release in rat melanotrophs. J Physiol 439: 37-58
107. Stille G, Lauener H, Eichenberger E, Hunziker, J Schmutz (1965) Arzneim-Forsch 15: 841
108. Stille G, Lauener H, Eichenberger E (1971) The pharmacology of 8-chloro-11-(4-methyl-1-piperazinyl)-5H-dibenzo(b,e,)(1,4) diazepine (clozapine). Farm-Ediz Prat 26: 603-625
109. 2 dopamine receptors in efflux of cyclic AMP from rat neostriatum. Nature 294: 366-368
110. Strange P G (1994) Dopamine D4 receptors: curiouser and curiouser. Trends Pharmac Sci 15: 317-319
111. 1. Nature 350: 614-619
112. 2 antagonist ritanserin blocks the effect of pre-frontal cortex inactivation on rat A10 dopamine neurones in vivo. Acta Physiol Scand 136: 497-498
113. 2+]i. Neurosci Lett 112: 205-209
114. 2+, excytosis, and endocytosis in single melanotrophs of the rat pituitary. Neuron 5: 723-733
115. Twarog B M, Page I H (1953) Serotonin content of some mammalian tissues and urine and method for its determination. Am J Physiol 175: 157-161
116. 2 receptor antagonist, activates midbrain dopamine neurons by blocking serotonergic inhibition. Psychopharmacology 98: 45-50
117. Vahabzeadeh A, Fillenz M (1992) Studies on the origin of rat hippocampal dihydroxyphenolacetic acid using microdialysis. Neurosci Letts 136: 51-55
118. Valentijn J A, Louiset E, Vaudry H, Cazin L (1991) Dopamine regulates the electrical activity of frog melanotrophs through a G protein-mediated mechanism. Neuroscience 44: 85-95
119. 4 receptor with high affinity for the antipsychotic clozapine. Nature 350: 610-614
120. 4 receptor variants in the human population. Nature 358: 149-162
121. Vogt M (1954) The concentration of sympathin in different parts of the central nervous system under normal conditions and after the administration of drugs. J Physiol 123: 451-481
122. 2 dopamine receptor mRNA in rat brain. Proc Nat Acad Sci USA 88: 1859-1863
123. 1 beta) and its pseudogene. J Biol Chem 266: 22427-22435
124. 2 dopamine receptors in drug-naive schizophrenics. Science 234: 1558-1563